- Home
- BMN vs LFCR Comparison
BMN vs LFCR Comparison
Compare BMN & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMN
- LFCR
- Stock Information
- Founded
- BMN 2020
- LFCR 1986
- Country
- BMN United States
- LFCR United States
- Employees
- BMN 19800
- LFCR N/A
- Industry
- BMN Trusts Except Educational Religious and Charitable
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- BMN Finance
- LFCR Health Care
- Exchange
- BMN Nasdaq
- LFCR Nasdaq
- Market Cap
- BMN 154.9M
- LFCR 164.3M
- IPO Year
- BMN N/A
- LFCR N/A
- Fundamental
- Price
- BMN $25.32
- LFCR $6.98
- Analyst Decision
- BMN
- LFCR Buy
- Analyst Count
- BMN 0
- LFCR 2
- Target Price
- BMN N/A
- LFCR $8.00
- AVG Volume (30 Days)
- BMN 29.9K
- LFCR 199.0K
- Earning Date
- BMN 01-01-0001
- LFCR 10-04-2024
- Dividend Yield
- BMN 4.66%
- LFCR N/A
- EPS Growth
- BMN N/A
- LFCR N/A
- EPS
- BMN N/A
- LFCR 0.17
- Revenue
- BMN N/A
- LFCR $128,443,999.00
- Revenue This Year
- BMN N/A
- LFCR $2.23
- Revenue Next Year
- BMN N/A
- LFCR $8.40
- P/E Ratio
- BMN N/A
- LFCR $41.70
- Revenue Growth
- BMN N/A
- LFCR 23.42
- 52 Week Low
- BMN $21.51
- LFCR $3.68
- 52 Week High
- BMN $25.59
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- BMN 57.84
- LFCR 61.28
- Support Level
- BMN $24.98
- LFCR $6.27
- Resistance Level
- BMN $25.31
- LFCR $7.23
- Average True Range (ATR)
- BMN 0.25
- LFCR 0.46
- MACD
- BMN 0.03
- LFCR 0.04
- Stochastic Oscillator
- BMN 93.49
- LFCR 53.88
About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.